[1] Plyusnin A. Genectics of hantaviruses: implications to taxonoxmy[J]. Arch Virol,2002,147 (4): 665.
[2] Mir MA, Panganiban AT. The bunyavirus nucleocapsid protein is an RNA chaperone: possible roles in viral RNA panhandle formation and genome replication[J]. RNA, 2006, 12(2):272-282.
[3] Taylor SL, FriasStaheli N, Garcia-Sastre A, et al. Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factoralpha-induced activation of nuclear factor kappa B[J]. J Virol, 2009, 83(3):1271-1279.
[4] Linderholm M, Elgh F. Clinical characteristics of hantavirus infections on the Eurasian continent[J]. Curr Top Microbiol Immunol, 2001, 256:135-151.
[5] Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness[J]. Science, 1993, 262(5135):914-917.
[6] Tamura M, Asada H, Kondo K, et al. Pathogenesis of Hantaan virus in mice[J]. J Gen Virol, 1989, 70 (11): 2897-2906.
[7] Tsai TF, Bauer S, McCormick JB, et al. Intracerebral inoculation of suckling mice with Hantaan virus [J]. Lancet, 1982, 2(8296):503-504.
[8] Wichmann D, Grone HJ, Frese M, et al. Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice[J]. J Virol, 2002, 76(17):8890-8899.
[9] McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue[J]. J Cell Biol, 1980, 85(3):890-902.
[10] Stoltz M, Klingstrom J. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection[J]. J Virol, 2010, 84(18):9140-9148.
[11] Xu Z, Wei L, Wang L, et al.The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immuni-zation[J]. Biochem Biophys Res Commun, 2002, 298(4):552-558.
[12] Rang A, Gunther S, Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells[J]. J Hepatol, 1999, 31(5):791-799.
[13] Shin OS, Yanagihara R, Song JW. Distinct innate immune responses in human macrophages and endothelial cells infected with shrew-borne hantaviruses[J]. Virology, 2012,434 (1):43-49.
[14] Hautala T, Hautala N, Mahonen SM, et al. Young male patients are at elevated risk of developing serious central nervous system complications during acute Puumala hantavirus infection[J]. BMC Infect Dis, 2011,11:217.
[15] Hautala T, Mahonen SM, Sironen T, et al. Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection[J]. Ann Med, 2010,42(5/6):344-351.
[16] Hautala T, Partanen T, Sironen T, et al. Elevated cerebro-spinal fluid neopterin concentration is associated with disease severity in acute Puumala hantavirus infection[J]. Clin Devel Immunol, 2013, 2013(1):634632.
[17] Hopkins RO, LarsonLohr V, Weaver LK, et al. Neuropsychological impairments following hantavirus pulmonary syndrome[J]. J Int Neuropsychol Soc, 1998,4(2):190-196.
[18] Li XD, Makela TP, Guo D, et al. Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx[J]. J Gen Virol, 2002, 83(4):759-766.
[19] Marsac D, Garcia S, Fournet A, et al. Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability[J]. Virol J, 2011, 8:223.
[20] Pensiero MN, Sharefkin JB, Dieffenbach CW, et al. Hantaan virus infection of human endothelial cells [J]. J Virol, 1992, 66(10):5929-5936.
[21] Yanagihara R, Silverman DJ. Experimental infection of human vascular endothelial cells by patho-genic and nonpathogenic hantaviruses[J]. Arch Virol, 1990, 111(3-4):281-286.[22] Yang Y, Yao H, Lu Y, et al. Cocaine potentiates astrocyte toxicity mediated by human immuno- deficiency virus (HIV-1) protein gp120[J]. PLoS One, 2010, 5(10):e13427.
|